Exploring the Theranostic Applications and Prospects of Nanobubbles

Overview

Journal Curr Pharm Biotechnol

Publisher Bentham Science Publishers

Specialties Biotechnology
Pharmacology

Date 2023 Oct 20

PMID 37861011

Authors

Rahul Shah

Niraj Phatak

Ashok Choudhary

Sakshi Gadewar

Ajazuddin

Sankha Bhattacharya

Affiliations

Soon will be listed here.

Abstract

Anticancer medications as well as additional therapeutic compounds, have poor clinical effectiveness due to their diverse distribution, non-selectivity for malignant cells, and undesirable off-target side effects. As a result, ultrasound-based targeted delivery of therapeutic compounds carried in sophisticated nanocarriers has grown in favor of cancer therapy and control. Nanobubbles are nanoscale bubbles that exhibit unique physiochemical properties in both their inner core and outer shell. Manufacturing nanobubbles primarily aims to enhance therapeutic agents' bioavailability, stability, and targeted delivery. The small size of nanobubbles allows for their extravasation from blood vessels into surrounding tissues and site-specific release through ultrasound targeting. Ultrasound technology is widely utilized for therapy due to its speed, safety, and cost-effectiveness, and micro/nanobubbles, as ultrasound contrast agents, have numerous potential applications in disease treatment. Thus, combining ultrasound applications with NBs has recently demonstrated increased localization of anticancer molecules in tumor tissues with triggered release behavior. Consequently, an effective therapeutic concentration of drugs/genes is achieved in target tumor tissues with ultimately increased therapeutic efficacy and minimal side effects on other non-cancerous tissues. This paper provides a brief overview of the production processes for nanobubbles, along with their key characteristics and potential therapeutic uses.

Citing Articles

Idarubicin-loaded chitosan nanobubbles to improve survival and decrease drug side effects in hepatocellular carcinoma.

Mossenta M, Argenziano M, Capolla S, Busato D, Durigutto P, Mangogna A Nanomedicine (Lond). 2025; 20(3):255-270.

PMID: 39815170 PMC: 11792799. DOI: 10.1080/17435889.2025.2452154.

References

Thirumalaivasan N, Venkatesan P, Lai P, Wu S . In Vitro and In Vivo Approach of Hydrogen-Sulfide-Responsive Drug Release Driven by Azide-Functionalized Mesoporous Silica Nanoparticles. ACS Appl Bio Mater. 2022; 2(9):3886-3896. DOI: 10.1021/acsabm.9b00481. View

Siegel R, Miller K, Jemal A . Cancer statistics, 2019. CA Cancer J Clin. 2019; 69(1):7-34. DOI: 10.3322/caac.21551. View

Borregaard R, Lukac P, Gerdes C, Moller D, Mortensen P, Pedersen L . Radiofrequency ablation of accessory pathways in patients with the Wolff-Parkinson-White syndrome: the long-term mortality and risk of atrial fibrillation. Europace. 2014; 17(1):117-22. DOI: 10.1093/europace/euu176. View

Taieb D, Jha A, Treglia G, Pacak K . Molecular imaging and radionuclide therapy of pheochromocytoma and paraganglioma in the era of genomic characterization of disease subgroups. Endocr Relat Cancer. 2019; 26(11):R627-R652. PMC: 7002202. DOI: 10.1530/ERC-19-0165. View

Shen Y, Lv W, Yang H, Cai W, Zhao P, Zhang L . FA-NBs-IR780: Novel multifunctional nanobubbles as molecule-targeted ultrasound contrast agents for accurate diagnosis and photothermal therapy of cancer. Cancer Lett. 2019; 455:14-25. DOI: 10.1016/j.canlet.2019.04.023. View

Kiessling F, Fokong S, Bzyl J, Lederle W, Palmowski M, Lammers T . Recent advances in molecular, multimodal and theranostic ultrasound imaging. Adv Drug Deliv Rev. 2013; 72:15-27. PMC: 4043517. DOI: 10.1016/j.addr.2013.11.013. View

Zhu G, Zhang Y, Wang K, Zhao X, Lian H, Wang W . Visualized intravesical floating hydrogel encapsulating vaporized perfluoropentane for controlled drug release. Drug Deliv. 2015; 23(8):2820-2826. DOI: 10.3109/10717544.2015.1101791. View

Shagdarsuren B, Tamai H, Shingaki N, Mori Y, Maeshima S, Nuta J . Contribution of Contrast-Enhanced Sonography With Perfluorobutane Microbubbles for Diagnosis of Recurrent Hepatocellular Carcinoma. J Ultrasound Med. 2016; 35(7):1383-91. DOI: 10.7863/ultra.15.08042. View

Pathak V, Nolte T, Rama E, Rix A, Dadfar S, Paefgen V . Molecular magnetic resonance imaging of Alpha-v-Beta-3 integrin expression in tumors with ultrasound microbubbles. Biomaterials. 2021; 275:120896. DOI: 10.1016/j.biomaterials.2021.120896. View

10.

Exner A, Kolios M . Bursting Microbubbles: How Nanobubble Contrast Agents Can Enable the Future of Medical Ultrasound Molecular Imaging and Image-Guided Therapy. Curr Opin Colloid Interface Sci. 2021; 54. PMC: 8356903. DOI: 10.1016/j.cocis.2021.101463. View

11.

Lajoinie G, van Rooij T, Skachkov I, Blazejewski E, Veldhuis G, de Jong N . Laser-Activated Polymeric Microcapsules for Ultrasound Imaging and Therapy: In Vitro Feasibility. Biophys J. 2017; 112(9):1894-1907. PMC: 5425399. DOI: 10.1016/j.bpj.2017.03.033. View

12.

Guvener N, Appold L, De Lorenzi F, Golombek S, Rizzo L, Lammers T . Recent advances in ultrasound-based diagnosis and therapy with micro- and nanometer-sized formulations. Methods. 2017; 130:4-13. DOI: 10.1016/j.ymeth.2017.05.018. View

13.

Deshpande N, Needles A, Willmann J . Molecular ultrasound imaging: current status and future directions. Clin Radiol. 2010; 65(7):567-81. PMC: 3144865. DOI: 10.1016/j.crad.2010.02.013. View

14.

Shakeri-Zadeh A, Zareyi H, Sheervalilou R, Laurent S, Ghaznavi H, Samadian H . Gold nanoparticle-mediated bubbles in cancer nanotechnology. J Control Release. 2020; 330:49-60. DOI: 10.1016/j.jconrel.2020.12.022. View

15.

Yang H, Cai W, Xu L, Lv X, Qiao Y, Li P . Nanobubble-Affibody: Novel ultrasound contrast agents for targeted molecular ultrasound imaging of tumor. Biomaterials. 2014; 37:279-88. DOI: 10.1016/j.biomaterials.2014.10.013. View

16.

Cavalli R, Soster M, Argenziano M . Nanobubbles: a promising efficient tool for therapeutic delivery. Ther Deliv. 2016; 7(2):117-38. DOI: 10.4155/tde.15.92. View

17.

Roovers S, Segers T, Lajoinie G, Deprez J, Versluis M, De Smedt S . The Role of Ultrasound-Driven Microbubble Dynamics in Drug Delivery: From Microbubble Fundamentals to Clinical Translation. Langmuir. 2019; 35(31):10173-10191. DOI: 10.1021/acs.langmuir.8b03779. View

18.

Abenojar E, Nittayacharn P, De Leon A, Perera R, Wang Y, Bederman I . Effect of Bubble Concentration on the in Vitro and in Vivo Performance of Highly Stable Lipid Shell-Stabilized Micro- and Nanoscale Ultrasound Contrast Agents. Langmuir. 2019; 35(31):10192-10202. DOI: 10.1021/acs.langmuir.9b00462. View

19.

Fateh S, Moradi L, Kohan E, Hamblin M, Shiralizadeh Dezfuli A . Comprehensive review on ultrasound-responsive theranostic nanomaterials: mechanisms, structures and medical applications. Beilstein J Nanotechnol. 2021; 12:808-862. PMC: 8372309. DOI: 10.3762/bjnano.12.64. View

20.

Su C, Ren X, Nie F, Li T, Lv W, Li H . Current advances in ultrasound-combined nanobubbles for cancer-targeted therapy: a review of the current status and future perspectives. RSC Adv. 2022; 11(21):12915-12928. PMC: 8697319. DOI: 10.1039/d0ra08727k. View